Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | GS | MS |
|---|---|---|
| Price | $921.29 | $196.66 |
| Change today | ▼ 1.61% | ▼ 0.87% |
| Market cap | $268.25B | $308.87B |
| Return, 3 months | -14.0% | -10.1% |
| Return, year to date | +6.3% | +12.6% |
| Return, 1 year | +18.5% | +27.4% |
| P/E (TTM) | 14.2 | 15.9 |
| P/B | 2.4 | 2.9 |
| P/E percentile vs own 5y | 51st | 64th |
| Dividend yield | 1.85% | 2.03% |
| Revenue growth (YoY, latest qtr) | +39.5% | +27.4% |
| Net profit growth (YoY) | +78.0% | +58.1% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | 30.3% | 26.8% |
| Return on equity | 18.3% | 19.1% |
| Analyst target vs. price | +30.6% | +24.8% |
| Analyst buy share | 46% | 57% |
| RSI (14) | 36 | 36 |
| 30-day volatility | 27.6% | 24.1% |
| Max drawdown, 1 year | -19.4% | -18.8% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.